HUP0300497A3
(en )
2004-10-28
Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP1383743A4
(en )
2006-04-12
Dual inhibitors of pde 7 and pde 4
IL241732A0
(en )
2015-11-30
Inhibitors of human phosphatidylinositol 3-kinase delta
HK1091810A1
(en )
2007-01-26
Inhibitors of phosphatidylinositol 3-kinase
HUP0302412A3
(en )
2007-02-28
Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
HUP0301005A3
(en )
2006-05-29
Pirrolotriazine inhibitors of kinases pharmaceutical compositions containing them and their use
GB0025782D0
(en )
2000-12-06
Use of inhibitors
HUP0402629A3
(en )
2009-09-28
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
HUP0201463A3
(en )
2004-06-28
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and their use
AU2002241520A1
(en )
2003-03-03
Blood assessment of injury
PL352547A1
(en )
2003-08-25
Drugs containing inhibitors of human kinase h-sgk
HUP0300061A3
(en )
2005-09-28
Use of il-18 inhibitors
HUP0302160A3
(en )
2005-05-30
Pharmaceutical compositions containing the combination of gaba agonists and sorbitol dehydrogenase inhibitors
ZA200208228B
(en )
2005-07-27
Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
HUP0304045A3
(en )
2005-05-30
Use of ikb-kinase inhibitors for treating of inflammatory and immune diseases and pharmaceutical compositions containing them
HK1062810A1
(en )
2004-11-26
Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
IL156506A0
(en )
2004-01-04
Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
HUP0401641A3
(en )
2007-02-28
Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002338734A1
(en )
2003-07-03
Use of phosphorodiesterase IV inhibitors
IL131047A0
(en )
2001-01-28
Use of il-18 inhibitors
SI1939203T1
(en )
2015-03-31
Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
AU2001255730A1
(en )
2001-11-07
Methods and compositions for the treatment of cardiac indications
HUP0303029A3
(en )
2004-11-29
Use of pharmaceutical compositions containing cgmp-5pde inhibitors for treatment of wounds
HUP0303497A3
(en )
2006-02-28
Pharmaceutical compositions containing combination of statins and sorbitol dehydrogenase inhibitors
AU2003216706A1
(en )
2004-07-22
Device for measurement of tissue hardness